Omada Health (Ticker: OMDA US) is a United States company specializing in virtual chronic care, offering programs for conditions such as prediabetes, diabetes, and hypertension, utilizing what it describes as a “between-visit care model”. Omada Health plans to list on Nasdaq on Friday, June 6, 2025. The company is offering 7.9 million common shares, with an expected IPO price between $18 and $20 per share, seeking to raise approximately $158 million (USD). This offering targets a valuation of about $1.1 billion (USD). Omada Health reportedly plans to use a portion of the IPO net proceeds for general corporate purposes, which may include working capital, operating expenses, capital expenditures, and potentially to repay outstanding borrowings under its Midcap credit agreement. Active bookrunners for the IPO include Morgan Stanley, Goldman Sachs, and J.P. Morgan.